How to read a compounded peptide label: strength, lot, and beyond-use date

01

Start with product identity, not the clinic program name

A clinic may market a membership, recovery plan, metabolic program, or branded protocol while a pharmacy label uses a different established ingredient name. Record both, but use the dispensed label to identify the actual drug product. The label should allow the patient, clinician, pharmacist, and regulator to describe the same container without guessing.

Look for the exact active ingredient or ingredients, salt form when stated, dosage form, route, concentration, total volume or quantity, and the name and location of the compounder. Combination products require every active ingredient to be identified. A nickname such as peptide blend is not enough to compare the product with a prescription, recall, or evidence source.

A label also does not decide whether the product is FDA-approved. FDA says compounded drugs are not FDA-approved and do not receive premarket review for safety, effectiveness, or quality. If the clinic uses approved, generic, compounded, off-label, and research terminology interchangeably, ask for a written classification.

02

Separate concentration from total amount

Injectable labels can express strength as an amount per milliliter and as the total amount in the container. Those values are related but not interchangeable. FDA has warned that differences in how compounders and conventional manufacturers display strength can contribute to dosing errors when a prominent per-milliliter value is mistaken for the total amount.

For small-volume parenteral products, FDA discusses showing strength per total volume prominently, with strength per milliliter nearby. Consumers should not redesign a label or perform an administration calculation themselves. The practical step is to compare the pharmacy label with the written prescription and contact the dispensing pharmacist when the unit, concentration, total volume, or directions are ambiguous.

Watch for unit changes such as milligrams, micrograms, milliliters, and non-metric syringe markings. A clinic portal, shipment insert, vial, and prescription should agree. A discrepancy is a stop signal, not an invitation to infer what the prescriber intended.

03

A beyond-use date is not an expiration date

USP explains that beyond-use dates and manufacturer expiration dates are different. An expiration date is assigned to a conventionally manufactured product, ingredient, or component using testing tied to a formulation, container, and storage conditions. A beyond-use date is assigned by a compounder to a compounded sterile or nonsterile preparation.

The BUD marks the date—or date and time—after which the compounded preparation must not be used. It is determined from when preparation begins. Storage conditions are part of the question: a date supported for refrigeration cannot be separated from the temperature, light, packaging, handling, and formulation assumptions behind it.

Do not extend a BUD because a vial looks clear, because medication remains, or because an ingredient’s manufacturer expiration date is later. Appearance cannot establish sterility or potency. Ask the compounder what formulation-specific stability and, where relevant, sterility information supports the assigned date.

04

Lot and prescription identifiers make the product traceable

Record the lot or batch number, prescription or order number, dispense date, compounder, and container size. These fields help distinguish two containers that share an ingredient name but were produced at different times, by different facilities, or under different conditions.

FDA’s MedWatch instructions say the labeler or distributor, manufacturer or compounder, labeled strength, NDC or unique identifier when available, and lot number are critical when evaluating product-quality problems. FDA also recommends attaching labeling or packaging when available. A clear photograph of every side of the original container can preserve that information.

An NDC may help identify listed label data, but it does not make a compounded drug FDA-approved. Similarly, a lot number enables traceability; it is not evidence that the batch passed every test or that the product is clinically appropriate.

05

Storage and handling language is product-specific

Read the stated storage range, light protection, freezing warning, container-position instruction, and any discard-after-opening language. Record how the shipment arrived and whether temperature-monitoring material was included, but do not assume that a cold package proves the product stayed within range throughout transit.

Generic internet instructions can be unsafe because two products with the same ingredient name may differ in formulation, concentration, preservative, container, or validated storage. Follow the dispensing pharmacy’s product-specific label and contact the pharmacist when a shipment was delayed, warm, frozen, damaged, cloudy, discolored, leaking, or particulate.

This guide intentionally does not give reconstitution, injection, dose, or storage-life instructions. Those depend on the exact product and prescription. A clinic should provide a direct route to the dispensing pharmacy for label and product-quality questions.

06

A pre-use label verification checklist

Compare the patient name or ordering facility, prescriber, ingredient, route, concentration, total amount, and directions across the prescription, pharmacy label, and shipment materials. Confirm the compounder independently. For a 503B product supplied to a clinic, federal law requires specific label and container information, including a statement that it is a compounded drug.

Pause if the ingredient is abbreviated, the compounder is hidden behind a clinic brand, the concentration conflicts with another document, units are unclear, the BUD or storage conditions are missing, the seal is damaged, or the label is unreadable. Contact the pharmacist and prescriber; do not rely on a social-media answer.

If there is a suspected adverse event, medication error, or quality defect, seek appropriate care and preserve the container, label, packaging, photos, dates, and correspondence. Those details can support a MedWatch report and any state-board or pharmacy follow-up.

• →Ingredient, route, and dosage form
• →Concentration and total amount
• →Compounder and prescription or order number
• →Lot, BUD, and storage
• →Readable directions and contact information